on prosthetic types (e.g., Provisional Bridge, Denture) for an expanded workflow. Medit revolutionized the market in 2018 with its first intraoral scanner, offering high precision and user-friendly options at a significantly lower cost than...
treating relapsed refractory AML patients with CLAG-M. Actimab-A + CLAG-M Trial Data Highlights from Publication: 18.4 month median Overall Survival (OS) in patients who received 1 or 2 lines of prior therapy 52% of patients in the Actimab-A...
by the couple's respective careers in biomedical science and art history. Since 2000, the foundation has awarded over $15 million in prizes and grants. The Vilcek Foundation is a private operating foundation, a federally tax-exempt nonprofit...
labelled, PSMA targeted, investigational radioligand therapy. Radiation dosimetry and pharmacokinetic data from the 13 metastatic castrate resistant prostate cancer patients enrolled in the Phase 1 portion of a Phase 1/2 clinical trial...
Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a Phase 1 clinical trial of FZ002 for C. difficile treatment. Oral FZ002 is a live yeast genetically modified to express a...
Currax Pharmaceuticals LLC a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE® (naltrexone HCl/bupropion HCl), announced the publication of its Cardiovascular Health Outcomes Analysis (HOA)...
CordenPharma provides development and manufacturing services for clinical and commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735, a Dual GLP-1/GIP Receptor Agonist, across the full supply chain from drug substance to drug product...
potential to transform the lives of individuals with immunodeficiency. About Kenox Pharmaceuticals Inc.: Established in 2018 and based in the greater Princeton area, NJ, Kenox specializes in pharmaceutical aerosol product development, including...
sustained clinical benefits across different adult patient populations living with this common inflammatory skin condition.1-4 "A primary treatment goal for people living with psoriasis is durable, high rates of complete skin clearance. These...
MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva...
In a significant development for the clinical diagnostics landscape in Singapore, Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics...
to provide necessary treatment options to patients with cancer.” In 2024, an estimated 9,280 people were diagnosed with CML1, over 10,000 with MDS/MPD2, and up to 6,000 with GIST3 in the U.S. Despite the proven clinical benefits of imatinib,...
("Latigo") announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to LTG-001, the company's oral, investigational selective Nav1.8 inhibitor for the treatment of acute pain. LTG-001 works by blocking...
lasting 30–60 minutes, depending on the size of the nodule. Patients remain under observation for an additional 60–120 minutes before discharge. Dr. Grady uses STARmed's industry-leading RF technology to ensure the highest standard of care with the...
TOOsonix A/S, a leader in high-intensity focused ultrasound technology for dermatology, has partnered with MikronMed AB, a top distributor of medical equipment in the Nordic region. The collaboration will bring TOOsonix innovative MDR CE marked...
Neurosurgeon Jeffrey Schweitzer, M.D., Ph.D., the George A. Lopez, MD Endowed Chair in Neurosurgery, is leading a Phase 1 trial at Mass General Brigham. “Using a patient’s own cells as a starting point has clear advantages such as minimizing...
biotherapeutics, announced the appointment of Ashley Scholz as Vice President of Marketing. Ashley brings over 16 years of experience in marketing leadership within the medical device, cancer diagnostics, and molecular diagnostics industries. In...
the leading clinical trials laboratories in Australia, managing large biotech and pharmaceutical clinical trials from Phase 1 to Phase 4 studies. With a vast network of laboratories across Australia, ACL Specialised Trials has extensive experience...
with Regemat 3D's mission to provide state-of-the-art bioprinting solutions. Regemat 3D has grown to become one of the top 15 3D bioprinting emerging companies worldwide, with a presence in more than 30 countries and collaborators in over 100...
studies in which humanized sickle cell mice topically treated with Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part...
